Search - tctmd.com

Displaying 1 - 20 of 42

Sort: Relevancy | Date

News Conference News TCT 2016

TAVR Provides ‘Acceptable’ Outcomes in Low-Flow, Low-Gradient Aortic Stenosis Patients With Poor Ventricular Function

November 01, 2016

Strategies to Reduce the Frequency of New Pacemakers After TAVR: Imaging, Procedural, and Device-Related Factors

Presentation TCT 2016

Strategies to Reduce the Frequency of New Pacemakers After TAVR: Imaging, Procedural, and Device-Related Factors

Presenter: Neil E. Moat, John G. Webb, Ian T. Meredith

October 31, 2016

Complications 4. Conduction Disturbances: Clinical Implications of New LBBB and New Pacemakers After TAVR

Presentation TCT 2016

Complications 4. Conduction Disturbances: Clinical Implications of New LBBB and New Pacemakers After TAVR

Presenter: Neil E. Moat, John G. Webb, Marina Urena

October 31, 2016

Pacemaker-Based Treatment for Hypertension (Backbeat)

Presentation TCT 2016

Pacemaker-Based Treatment for Hypertension (Backbeat)

Presenter: Darren Sherman

October 31, 2016

Debate: ICD or Pacemaker for High Grade AV Block After Alcohol Septal Ablation: Pro Pacing

Presentation TCT 2016

Debate: ICD or Pacemaker for High Grade AV Block After Alcohol Septal Ablation: Pro Pacing

Presenter: Bernard J. Gersh, Harry Rakowski, Michael A. Fifer

October 30, 2016

Debate: ICD or Pacemaker for High Grade AV Block After Alcohol Septal Ablation: Pro ICD!

Presentation TCT 2016

Debate: ICD or Pacemaker for High Grade AV Block After Alcohol Septal Ablation: Pro ICD!

Presenter: Bernard J. Gersh, Harry Rakowski, George S. Hanzel

October 30, 2016

News Conference News TCT 2016

Transcaval TAVR Presents New Option for Patients With Complex Anatomy

Yael L. Maxwell

October 29, 2016

Conduction Disturbances (New LBBB and Pacemakers) After TAVR: Frequency, Clinical Impact, and Management Considerations

Presentation TCT 2015

Conduction Disturbances (New LBBB and Pacemakers) After TAVR: Frequency, Clinical Impact, and Management Considerations

Presenter: Isaac George, Augusto D. Pichard, Susheel Kodali

October 15, 2015

News Conference News TCT 2015

Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves

October 15, 2015

News Conference News TCT 2015

Low 1-Year Event Rates Seen After TAVR With Sapien 3

October 15, 2015

Risk of Paradoxical Embolism With Pacemaker Leads

Presentation TCT 2015

Risk of Paradoxical Embolism With Pacemaker Leads

Presenter: John D. Carroll, Mark Reisman, Samir R. Kapadia

October 14, 2015

News Conference News TCT 2015

Updates to CoreValve Extreme Risk Study Encouraging

October 13, 2015

News Conference News TCT 2015

Robotic Systems to Play Greater Role in Cath Lab of the Future

October 12, 2015

News Conference News TCT 2015

First-in-Human Studies: Novel Devices for Aortic Valve Stenosis Safe, Feasible

October 12, 2015

News Conference News TCT 2015

CoreValve Extreme Risk Pivotal Trial: Improved Benefits Confirmed After 3 Years

October 12, 2015

News Conference News TCT 2015

Boston Scientific Co-founder John Abele Recognized by TCT Career Achievement Award

October 12, 2015

How to Prevent Annular Rupture, Coronary Occlusion, and Permanent Pacemakers

Presentation TCT 2015

How to Prevent Annular Rupture, Coronary Occlusion, and Permanent Pacemakers

Presenter: Ricardo Lluberas, Roxana Mehran, Jamil Abdalla Saad, Oscar A. Mendiz

October 11, 2015

Predictors and Clinical Outcomes of Permanent Pacemaker Implantation After TAVR

Presentation TCT 2015

Predictors and Clinical Outcomes of Permanent Pacemaker Implantation After TAVR

Presenter: Marian C. Hawkey, Ganesh Manoharan

October 11, 2015

News Conference News TCT 2015

Global TAVR Market Poised to Exceed DES Market by 2025

October 11, 2015

TCT 63: Objective Assessment of Intracardiac Conduction to Guide Permanent Pacemaker Implantation Following Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

Presentation TCT 2014

TCT 63: Objective Assessment of Intracardiac Conduction to Guide Permanent Pacemaker Implantation Following Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

Presenter: Igor F. Palacios, Augusto D. Pichard, Kishore J. Harjai, Malek Al-Hawwas, MD

September 16, 2014

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.